OX40 Ligand

OX40 Ligand

OX40 Ligand 詳細

Molecule Name
Tumor necrosis factor ligand superfamily member 4
分子の別称
OX40L,TNFSF4,CD252,Glycoprotein Gp34,TXGP1,CD134 ligand,CD134L
Drug Development Progress
治験薬の数13
市販薬剤の数0
研究&開発段階Phase 3 Clinical
ターゲットの別称
CD134L,OX-40L,TNLG2B,OX4OL,GP34,CD252 Antigen,CD134 Ligand,TAX transcriptionally-activated glycoprotein 1,Tax-Transcriptionally Activated Glycoprotein 1, 34kD,CD252,OX40 ligand,OX40L,TNFSF4,Tumor necrosis factor ligand superfamily member 4,Glycoprotein Gp34,TNF Superfamily Member 4,TXGP1,Tax-Transcriptionally Activated Glycoprotein 1 (34kD),Tumor Necrosis Factor (Ligand) Superfamily, Member 4,Tumor Necrosis Factor (Ligand) Superfamily Member 4,Tumor Necrosis Factor Superfamily Member 4,Tumor Necrosis Factor Ligand 2B,OX40 Antigen Ligand
バックグランド
Tumor necrosis factor ligand superfamily member 4 (TNFSF4) is also known as glycoprotein Gp34, OX40 ligand (OX40L), TAX transcriptionally-activated glycoprotein 1 and CD252, which belongs to the tumor necrosis factor family. TNFSF4 is the ligand for CD134 and is expressed on such cells as DC2s (a subtype of dendritic cells) enabling amplification of Th2 cell differentiation. The interaction of TNFSF4-TNFSF4 is involved in the pathogenesis of multiple autoimmune and inflammatory diseases such as systemic lupus erythematosus (SLE), carotid artery disease and cancer. Furthermore, similar to other TNF superfamily members, membrane-bound OX40 Ligand (TNFSF4) exists as a homotrimer. Human TNFSF4 shares 46% amino acid sequence identity with its mouse counterpart.

OX40 Ligand 製品リスト

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
AmlitelimabKY-1005; SAR-445229Phase 3 ClinicalKymab Ltd, Sanofi
Alopecia Areata; Asthma; Celiac Disease; Dermatitis, Atopic; Eczema; Hidradenitis; Immune System Diseases; Lung Diseases, Interstitial; Scleroderma, Systemic
詳細
APG-279APG279; APG-990/APG777Phase 2 ClinicalApogee Therapeutics Inc
Dermatitis, Atopic
詳細
IMB-101 (IMBiologics)IMB-101 (IMBiologics); HDM-3019; IMB101 (IMBiologics); HDM3019; NAV-240Phase 2 ClinicalIMBiologics Corp
Arthritis, Rheumatoid; Hidradenitis Suppurativa
詳細
IBI356IBI-356; IBI356Phase 2 Clinical
Autoimmune Diseases; Dermatitis, Atopic
詳細
RP-3RP-3Phase 2 ClinicalReplimune Inc
Biliary Tract Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck
詳細
HS-130HS-130Phase 1 ClinicalHeat Biologics
Solid tumours
詳細
mRNA-2752mRNA-2752Phase 1 ClinicalAstrazeneca Plc, Moderna Inc
Lymphoma; Neoplasms; Solid tumours
詳細
MQ-710MQ-710Phase 1 ClinicalImvaq Therapeutics Corp, Memorial Sloan Kettering Cancer Center
Adenocarcinoma, Sebaceous; Basal Cell Nevus Syndrome; Carcinoma, Basal Cell; Carcinoma, Merkel Cell; Carcinoma, Squamous Cell; Hemangiosarcoma; Melanoma; Neoplasm Metastasis; Neoplasms; Paget Disease, Extramammary; Sarcoma, Kaposi; Solid tumours; Squamous Cell Carcinoma of Head and Neck
詳細
OX-118OX-118Phase 1 ClinicalOxion Biologics AB
Autoimmune Diseases; Immune System Diseases; Rheumatic Diseases
詳細
M-5542M5542; M-5542Phase 1 ClinicalMerck & Co Inc
詳細
ABCL-575ABCL-575; ABCL575Phase 1 ClinicalAbCellera Biologics Inc
Dermatitis, Atopic
詳細
APG-990APG-990; APG990; PR-007; PR007Phase 1 ClinicalParagon Therapeutics Inc
Dermatitis, Atopic
詳細
SAR-443726SAR-443726Phase 1 ClinicalSanofi
Dermatitis, Atopic
詳細